- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
New Survey Finds NPs and PAs Shift Preferences for Engagement with Life Sciences Companies Amidst COVID-19
Point of Care Network (POCN), an NP and PA network, today released a new survey featuring how 153 NPs and PAs are engaging with life sciences companies in light of the COVID-19 pandemic. Some of the information touched on was the shifting roles and responsibilities of NPs and PAs, ideas to support them to improve patient care, and how they would like to receive communications.
The survey found that COVID-19 has significantly shifted both NPs’ and PAs’ roles and responsibilities. Not surprisingly, 95 percent of the respondents reported that telehealth has had a large impact on their interactions with patients.
Pre-pandemic, in a previous POCN survey, nearly 59 percent of the respondents used conferences to receive information from life sciences companies. In light of newly cancelled events, NPs and PAs are embracing virtual communications even more. In this new survey, the overwhelming majority wants to be reached electronically, through emails, journals, KOL webinars, and are open to virtual rep visits. Finally, the types of conference-style information they want to see most from life sciences companies are prescribing and treatment guidelines, patient assistance programs, disease info, samples, and copay cards.
For the full survey, click here.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
